Abstract | OBJECTIVE: To evaluate the therapeutic efficacy of transcatheter arterial chemoembolization (TACE) combined with external radiotherapy (RT) for primary liver cancer. METHODS: The effectiveness of combined therapy with TACE and RT (76 cases) and TACE therapy alone (68 cases) was prospectively nonrandomly studied. RESULTS: In TACE + RT group, the response rate (CR + PR) was 53.9%, and the 1-, 2-, 3-year survival rate was 71.6%, 49.0%, and 44.5%, respectively. In contrast, the response rate of TACE alone was 33.8%, and the 1-, 2-, 3-year survival rate was 51.8%, 17.3%, and 17.3%, respectively. The difference between these two groups was statistically significant (P < 0.05). Factors of prognostic significance in the TACE + RT group were tumor type, tumor cell thrombi in the portal system, number of TACE treatment and the use of gelform in embolization. CONCLUSION: TACE + RT is more effective than TACE therapy alone. Understanding of the prognostic factors is useful for selection and management of patients.
|
Authors | W Guo, M Song, E Yu |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 21
Issue 1
Pg. 25-8
(Jan 1999)
ISSN: 0253-3766 [Print] China |
PMID | 11776790
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Chemoembolization, Therapeutic
- Combined Modality Therapy
- Female
- Humans
- Liver Neoplasms
(mortality, radiotherapy, therapy)
- Male
- Middle Aged
- Survival Rate
- alpha-Fetoproteins
(analysis)
|